Langerhans Cell Histiocytosis - 28 Studies Found
Active, not recruiting |
: Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis : Langerhans Cell Histiocytosis of Lung : 2011-10-14 : Drug: Cladribine Subcutaneous injections, 0,1 mg/kg/day for 5 days, one course per month for 4 months |
Completed |
: Prospective Evaluation of Adult Pulmonary Langerhans Cell Histiocytosis : Adult Pulmonary Langerhans Cell Histiocytosis : 2010-10-12 : Behavioral: Tabacco discontinuation Tabacco discontinuation |
Withdrawn |
: Clofarabine for Langerhans in Pedi : Langerhans Cell Histiocytosis : 2013-02-19 : Drug: Clofarabine |
Completed |
: Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH : Langerhans Cell Histiocytosis : 2007-12-26 :
|
Terminated |
: Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis : Histiocytosis, Langerhans-cell : 2008-02-19 :
|
Completed |
: Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL : Histiocytosis, Langerhans-Cell : 2002-10-30 : Drug: Etanercept |
Completed |
: H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis : Leukemia : 2007-06-14 :
|
Recruiting |
: A Study of Lenalidomide for Adult Histiocyte Disorders :
|
Recruiting |
: Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement :
: |
Recruiting |
: Cardiovascular Risk Factors and LCH in Adults : Histiocytosis, Langerhans-Cell : 2007-06-06 |